ALLO - Allogene Therapeutics, Inc.
IEX Last Trade
2.12
0.030 1.415%
Share volume: 17,261
Last Updated: Thu 26 Dec 2024 08:30:18 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$2.09
0.03
1.44%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-09 | 2022-11-02 | 2023-02-28 | 2023-05-03 | 2023-08-02 | 2023-11-02 | 2024-03-14 | 2024-05-13 | |
| Total revenue | 86.000 K | 49.000 K | 47.000 K | 52.000 K | 44.000 K | 43.000 K | -44.000 K | 22.000 K | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 86.000 K | 49.000 K | 47.000 K | 52.000 K | 44.000 K | 43.000 K | -44.000 K | 22.000 K | |
| -43.02% | -4.08% | 10.64% | -15.38% | -2.27% | -202.33% | 150.00% | |||
| Operating expenses | 76.680 M | 82.538 M | 96.421 M | 99.122 M | 80.562 M | 63.018 M | 71.885 M | 69.526 M | |
| Selling general and admin | 19.509 M | 18.897 M | 21.002 M | 18.884 M | 18.524 M | 17.041 M | 17.224 M | 17.267 M | |
| Research and development | 57.171 M | 63.641 M | 75.419 M | 80.238 M | 62.038 M | 45.977 M | 54.661 M | 52.259 M | |
| Total expenses | 76.680 M | 82.538 M | 96.421 M | 99.122 M | 80.562 M | 63.018 M | 71.885 M | 69.526 M | |
| 7.64% | 16.82% | 2.80% | -18.72% | -21.78% | 14.07% | -3.28% | |||
| Operating income | -76.594 M | -82.489 M | -96.374 M | -99.070 M | -80.518 M | -62.975 M | -71.929 M | -69.504 M | |
| Ebit | -76.594 M | -82.489 M | -96.374 M | -99.070 M | -80.518 M | -62.975 M | -71.929 M | -69.504 M | |
| Pretax income | -74.787 M | -83.148 M | -94.847 M | -98.704 M | -77.989 M | -61.315 M | -89.257 M | -65.000 M | |
| 11.18% | 14.07% | 4.07% | -20.99% | -21.38% | 45.57% | -27.18% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -74.787 M | -83.148 M | -94.847 M | -98.704 M | -77.989 M | -61.315 M | -89.257 M | -65.000 M | |
| -11.18% | -14.07% | -4.07% | 20.99% | 21.38% | -45.57% | 27.18% | |||
| Net income | -74.787 M | -83.148 M | -94.847 M | -98.704 M | -77.989 M | -61.315 M | -89.257 M | -65.000 M | |
| -11.18% | -14.07% | -4.07% | 20.99% | 21.38% | -45.57% | 27.18% |